Jacob Pontoppidan Thyssen
Professor, emeritus
- 2023
- Published
Drug survival of adalimumab, secukinumab, and ustekinumab in psoriasis as determined by either dose escalation or drug discontinuation during the first 3 years of treatment - a nationwide cohort study
Thein, D., Rosenø, N. A. L., Maul, J., Wu, J. J., Skov, Lone, Bryld, Lars Erik, Rasmussen, M. K., Ajgeiy, K. K., Thomsen, Simon Francis, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2023, In: Journal of Investigative Dermatology. 143, 11, 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics
Thyssen, Jacob Pontoppidan, Thaçi, D., Bieber, T., Gooderham, M., de Bruin-Weller, M., Soong, W., Kabashima, K., Barbarot, S., Luna, P. C., Xu, J., Hu, X., Liu, Y., Raymundo, E. M., Calimlim, B. M., Nduaka, C., Gamelli, A. & Simpson, E. L., 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 9, p. 1871-1880 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis
Thyssen, Jacob Pontoppidan, Bieber, T., Kleyn, C. E., Nosbaum, A., Grond, S., Petto, H., Riedl, E. & Wollenberg, A., 2023, In: Journal of Dermatological Treatment. 34, 1, 9 p., 2216322.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16
Thyssen, Jacob Pontoppidan, de Bruin-Weller, M., Costanzo, A., Grond, S., Schuster, C., Liu, C., Rueda, M. J., Chen, Y. F., Pinter, A. & Bieber, T., 2023, In: Advances in Therapy. 40, 8, p. 3574-3587 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comorbidities of atopic dermatitis—what does the evidence say?
Thyssen, Jacob Pontoppidan, Halling, A. S., Schmid-Grendelmeier, P., Guttman-Yassky, E. & Silverberg, J. I., 2023, In: Journal of Allergy and Clinical Immunology. 151, 5, p. 1155-1162Research output: Contribution to journal › Review › Research › peer-review
- Published
Long-term disease control in atopic dermatitis using biologics
Thyssen, Jacob Pontoppidan & Schmid-Grendelmeier, P., 2023, In: The Lancet. 401, 10372, p. 172-173 2 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial
Thyssen, Jacob Pontoppidan, Werfel, T., Barbarot, S., Hunter, H. J. A., Pierce, E., Sun, L., Cirri, L., Buchanan, A. S., Lu, N. & Wollenberg, A., 2023, In: Journal of Dermatological Treatment. 34, 1, 9 p., 2190430.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Association Between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study
Thyssen, Jacob Pontoppidan, Nymand, L. K. K., Maul, J., Schmid-Grendelmeier, P., Wu, J. J. J., Frostrup, A. G., Gren, S. T., Thomsen, Simon Francis & Egeberg, Alexander, 2023, In: Dermatitis. 34, 5, p. 361-473 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Short-term real-world experience with baricitinib treatment in Danish adults with moderate-severe atopic dermatitis
Vittrup, I., Elberling, Jesper Vraamark, Skov, Lone, Ibler, Kristina Sophie, Jemec, Gregor, Mortz, C. G., Bach, R. O., Bindslev-Jensen, C., Dalager, M. G., Egeberg, Alexander, Kamstrup, M., Deleuran, M., Vestergaard, C. & Thyssen, Jacob Pontoppidan, 2023, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 37, 4, p. e543-e546Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Disease burden of moderate–severe atopic dermatitis by use of systemic treatment: Results from the Danish Skin Cohort
Vittrup, I., Frøstrup, A. G., Gren, S. T., Thomsen, Simon Francis, Wu, J. J., Schmid‐grendelmeier, P., Maul, J. ‐., Egeberg, Alexander & Thyssen, Jacob Pontoppidan, 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 5, p. e688-e690 3 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
ID: 33972183
Most downloads
-
233
downloads
Expression of filaggrin and its degradation products in human skin following erythemal doses of ultraviolet B irradiation
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
228
downloads
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
187
downloads
Skin disorders in Parkinson's disease: potential biomarkers and risk factors
Research output: Contribution to journal › Review › Research › peer-review
Published